ALB and liver disorder: Univariate logistic regression analysis indicated significantly higher risks of treatment failure among patients with more advanced liver disease, as indicated by baseline MELD score ≥ 16 (odds ratio [OR], 6.58; 95% CI, 1.37–31.6), CTP class B or C (OR, 5.24; 95% CI, 1.84–14.9), albumin levels < 3.5 g/dL (OR, 3.96; 95% CI, 1.62–9.67), total bilirubin ≥1.2 mg/dL (OR, 4.27; 95% CI, 1.68–10.8), or platelet counts < 100 × 109/L (OR, 3.19; 95% CI, 1.30–7.82).